Literature DB >> 23463234

Deciphering microRNA code in pain and inflammation: lessons from bladder pain syndrome.

Ali Hashemi Gheinani1, Fiona C Burkhard, Katia Monastyrskaya.   

Abstract

MicroRNAs (miRNAs), a novel class of molecules regulating gene expression, have been hailed as modulators of many biological processes and disease states. Recent studies demonstrated an important role of miRNAs in the processes of inflammation and cancer, however, there are little data implicating miRNAs in peripheral pain. Bladder pain syndrome/interstitial cystitis (BPS/IC) is a clinical syndrome of pelvic pain and urinary urgency/frequency in the absence of a specific cause. BPS is a chronic inflammatory condition that might share some of the pathogenetic mechanisms with its common co-morbidities inflammatory bowel disease (IBD), asthma and autoimmune diseases. Using miRNA profiling in BPS and the information about validated miRNA targets, we delineated the signaling pathways activated in this and other inflammatory pain disorders. This review projects the miRNA profiling and functional data originating from the research in bladder cancer and immune-mediated diseases on the BPS-specific miRNAs with the aim to gain new insight into the pathogenesis of this enigmatic disorder, and highlighting the common regulatory mechanisms of pain and inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23463234     DOI: 10.1007/s00018-013-1275-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  165 in total

1.  The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.

Authors:  Shu Zhu; Wen Pan; Xinyang Song; Yan Liu; Xinrui Shao; Yuanjia Tang; Dong Liang; Dongyi He; Honglin Wang; Wenjun Liu; Yufang Shi; John B Harley; Nan Shen; Youcun Qian
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

2.  Acid-sensing channels in human bladder: expression, function and alterations during bladder pain syndrome.

Authors:  Verónica Sánchez-Freire; Maxime G Blanchard; Fiona C Burkhard; Thomas M Kessler; Stephan Kellenberger; Katia Monastyrskaya
Journal:  J Urol       Date:  2011-08-19       Impact factor: 7.450

3.  Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma.

Authors:  Francisco Ayala de la Peña; Keizo Kanasaki; Megumi Kanasaki; Neelima Tangirala; Genta Maeda; Raghu Kalluri
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

4.  The Role of MicroRNA in Inflammatory Bowel Disease.

Authors:  Sushila R Dalal; John H Kwon
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-11

5.  MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2).

Authors:  Seonhoe Kim; Ui Jin Lee; Mi Na Kim; Eun-Ju Lee; Ji Young Kim; Mi Young Lee; Sorim Choung; Young Joo Kim; Young-Chul Choi
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

6.  Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.

Authors:  Qingli Shen; Vito R Cicinnati; Xiaoyong Zhang; Speranta Iacob; Frank Weber; Georgios C Sotiropoulos; Arnold Radtke; Mengji Lu; Andreas Paul; Guido Gerken; Susanne Beckebaum
Journal:  Mol Cancer       Date:  2010-08-27       Impact factor: 27.401

7.  Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis.

Authors:  Gennady Slobodov; Michael Feloney; Christopher Gran; Kimberly D Kyker; Robert E Hurst; Daniel J Culkin
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450

8.  Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis.

Authors:  X Pang; W Boucher; G Triadafilopoulos; G R Sant; T C Theoharides
Journal:  Urology       Date:  1996-03       Impact factor: 2.649

9.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Authors:  Yuanjia Tang; Xiaobing Luo; Huijuan Cui; Xuming Ni; Min Yuan; Yanzhi Guo; Xinfang Huang; Haibo Zhou; Niek de Vries; Paul Peter Tak; Shunle Chen; Nan Shen
Journal:  Arthritis Rheum       Date:  2009-04

10.  Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

Authors:  P Dong; M Karaayvaz; N Jia; M Kaneuchi; J Hamada; H Watari; S Sudo; J Ju; N Sakuragi
Journal:  Oncogene       Date:  2012-07-30       Impact factor: 9.867

View more
  19 in total

1.  Computational functional genomics based analysis of pain-relevant micro-RNAs.

Authors:  Jörn Lötsch; Ellen Niederberger; Alfred Ultsch
Journal:  Hum Genet       Date:  2015-09-18       Impact factor: 4.132

2.  MicroRNA MiR-199a-5p regulates smooth muscle cell proliferation and morphology by targeting WNT2 signaling pathway.

Authors:  Ali Hashemi Gheinani; Fiona C Burkhard; Hubert Rehrauer; Catharine Aquino Fournier; Katia Monastyrskaya
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

3.  Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform.

Authors:  Nicolaas H Fourie; Ralph M Peace; Sarah K Abey; LeeAnne B Sherwin; John W Wiley; Wendy A Henderson
Journal:  J Vis Exp       Date:  2016-11-30       Impact factor: 1.355

4.  Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome.

Authors:  Nicolaas H Fourie; Ralph Michael Peace; Sarah K Abey; LeeAnne B Sherwin; Bridgett Rahim-Williams; Paul A Smyser; John W Wiley; Wendy A Henderson
Journal:  Exp Mol Pathol       Date:  2014-04-21       Impact factor: 3.362

5.  Characterization of miRNA-regulated networks, hubs of signaling, and biomarkers in obstruction-induced bladder dysfunction.

Authors:  Ali Hashemi Gheinani; Bernhard Kiss; Felix Moltzahn; Irene Keller; Rémy Bruggmann; Hubert Rehrauer; Catharine Aquino Fournier; Fiona C Burkhard; Katia Monastyrskaya
Journal:  JCI Insight       Date:  2017-01-26

Review 6.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

7.  Concordant miRNA and mRNA expression profiles in humans and mice with bladder outlet obstruction.

Authors:  Ali Hashemi Gheinani; Ivonne Köck; Evalynn Vasquez; Ulrich Baumgartner; Alexander Bigger-Allen; Bryan S Sack; Fiona C Burkhard; Rosalyn M Adam; Katia Monastyrskaya
Journal:  Am J Clin Exp Urol       Date:  2018-12-20

8.  Bladder overactivity involves overexpression of MicroRNA 132 and nerve growth factor.

Authors:  Mahendra Kashyap; Subrata Pore; Michael Chancellor; Naoki Yoshimura; Pradeep Tyagi
Journal:  Life Sci       Date:  2016-10-25       Impact factor: 5.037

9.  Circulating microRNA Signatures in Rodent Models of Pain.

Authors:  Rehman A Qureshi; Yuzhen Tian; Marguerite K McDonald; Kathryn E Capasso; Sabrina R Douglas; Ruby Gao; Irina A Orlova; James E Barrett; Seena K Ajit; Ahmet Sacan
Journal:  Mol Neurobiol       Date:  2015-06-18       Impact factor: 5.590

Review 10.  Epigenetic regulation of persistent pain.

Authors:  Guang Bai; Ke Ren; Ronald Dubner
Journal:  Transl Res       Date:  2014-05-29       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.